InícioPodcastsThe Long Run with Luke TimmermanEp188: Art Krieg on Innate Immune System Activators for CancerThe Long Run with Luke TimmermanEp188: Art Krieg on Innate Immune System Activators for Cancer28 de outubro de 2025 · 1 h 9 minTocar episódioCompartilhar a partir daquiNotas do episódioArt Krieg, founder and CEO of Zola Therapeutics, on developing innate immune system activators for cancer.Todos os episódios de The Long Run with Luke Timmerman